Australian Research Targets Diabetes Hope for CF Patients
A breakthrough cystic fibrosis drug may also transform diabetes outcomes for 30% of Australian CF patients who develop the condition. New research will investigate whether Trikafta can prevent or slow cystic fibrosis-related diabetes.
